Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease.

Area of Science:

• Microbiome research
• Gastroenterology
• Clinical diagnostics

Background:

• Altered gut microbiota is linked to inflammatory bowel disease (IBD).
• Current gut microbiota analysis lacks standardization, hindering clinical application.
• Interlaboratory and inter-platform variations pose significant challenges.

Purpose of the Study:

• To investigate the impact of between-hospital and between-platform variations on IBD predictive accuracy.
• To identify robust methods for gut microbiota profiling in clinical settings.
• To contribute to the development of a standardized noninvasive IBD diagnostic test.

Main Methods:

• Analysis of fecal samples from pediatric IBD patients and healthy children.
• Utilized IS-pro for standardized microbiota composition characterization.
• Simulated perturbations using synthetic data and validated in replicate datasets across different labs and platforms.

Main Results:

• Between-platform variations had a greater impact on predictive accuracy than between-laboratory variations.
• Random forest classifier demonstrated robustness against simulated and real-world perturbations.
• High accuracy was maintained even with data processed in different laboratories.

Conclusions:

• Robust clinical predictions using gut microbiota are feasible despite inter-laboratory and inter-platform variations.
• Random forest offers a reliable approach for microbiota-based diagnostics.
• This work supports the development of a universal IBD test for diagnosis and monitoring.